CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands		Total	Total Stockholders’ Equity of WSFS	Common Stock	Capital in Excess of Par Value	Accumulated Other Comprehensive Loss	Retained Earnings	Treasury Stock	Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2021				57,695,676
Beginning balance at Dec. 31, 2021		$ 1,937,016	$ 1,939,099	$ 577	$ 1,058,997	$ (37,768)	$ 1,224,614	$ (307,321)	$ (2,083)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		222,648	222,375				222,375		273
Other comprehensive (loss) income		(638,076)	(638,076)			(638,076)
Cash dividend		(35,746)	(35,746)				(35,746)
Distributions to noncontrolling shareholders		(504)							(504)
Issuance of common stock including proceeds from exercise of common stock options (in shares)				109,473
Issuance of common stock including proceeds from exercise of common stock options		3,179	3,179	$ 1	3,178
Issuance of common stock in acquisition of BMT (in shares)				18,116,848
Issuance of common stock in acquisition of BMT		908,016	908,016	$ 181	907,835
Noncontrolling interest assumed in acquisition		(913)							(913)
Stock-based compensation expense		6,349	6,349		6,349
Repurchases of common stock	[1]	(200,083)	(200,083)		(2,149)			(197,934)
Ending balance (in shares) at Dec. 31, 2022				75,921,997
Ending balance at Dec. 31, 2022		2,201,886	2,205,113	$ 759	1,974,210	(675,844)	1,411,243	(505,255)	(3,227)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		269,025	269,156				269,156		(131)
Other comprehensive (loss) income		81,853	81,853			81,853
Cash dividend		(36,742)	(36,742)				(36,742)
Distributions to noncontrolling shareholders		(4,463)							(4,463)
Issuance of common stock including proceeds from exercise of common stock options (in shares)				173,097
Issuance of common stock including proceeds from exercise of common stock options		3,298	3,298	$ 2	3,296
Stock-based compensation expense		9,605	9,605		9,605
Repurchases of common stock	[1]	(54,647)	(54,647)		(2,365)			(52,282)
Ending balance (in shares) at Dec. 31, 2023				76,095,094
Ending balance at Dec. 31, 2023		2,469,815	2,477,636	$ 761	1,984,746	(593,991)	1,643,657	(557,537)	(7,821)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		263,495	263,671				263,671		(176)
Other comprehensive (loss) income		(30,886)	(30,886)			(30,886)
Cash dividend		(35,805)	(35,805)				(35,805)
Distributions to noncontrolling shareholders		(3,299)	(920)		(920)				(2,379)
Issuance of common stock including proceeds from exercise of common stock options (in shares)	[2]			169,117
Issuance of common stock including proceeds from exercise of common stock options	[2]	466	466	$ 2	464
Stock-based compensation expense		11,901	11,901		11,901
Repurchases of common stock	[1]	(96,311)	(96,311)		0			(96,311)
Ending balance (in shares) at Dec. 31, 2024				76,264,211
Ending balance at Dec. 31, 2024		$ 2,579,376	$ 2,589,752	$ 763	$ 1,996,191	$ (624,877)	$ 1,871,523	$ (653,848)	$ (10,376)

[1] Repurchase of common stock for the years ended December 31, 2024, 2023 and 2022 included 2,049,739, 1,247,178 and 4,151,117 shares repurchased, respectively, in connection with the Company's share buyback program approved by the Board of Directors. The years ended December 31, 2023 and 2022 included 45,489 and 113,039 shares withheld, respectively, to cover tax liabilities.

[2] Issuance of common stock includes 54,972 shares withheld to cover tax liabilities.